Ownership Summary
Aethlon Medical Inc (NASDAQ:AEMD) currently has 6 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
- Institutional ownership in Aethlon Medical edged down to 1.0% in December 2025, compared to 127.1% in September 2025.
- In percentage terms, this reflects as a holdings change of nan% quarter on quarter, and a decrease of 75.00% year over year.
- The latest 13F cycle for Aethlon Medical reveals that of 6 total investors, 6 funds grew their exposure, whereas 0 reduced theirs and 0 made no changes.
- Collectively, institutional investors increased their stake in Aethlon Medical to 2.11K shares as of December 2025, a change that is up by 2.11K shares quarter on quarter and down 1.60Mn shares year over year.
- With 2.05K shares, MORGAN STANLEY commands the largest institutional position in Aethlon Medical as of December 31, 2025, equating to 0.92% of the company.
- Among the most significant buyers of Aethlon Medical during December 2025 were MORGAN STANLEY (2.05K), CITIGROUP INC (33), GROUP ONE TRADING LLC (14), BlackRock, Inc. (10), BANK OF AMERICA CORP /DE/ (6).
- The top 6 institutional holders of Aethlon Medical for the quarter ending December 2025 included MORGAN STANLEY (2.05K), CITIGROUP INC (33), GROUP ONE TRADING LLC (14), BlackRock, Inc. (10), BANK OF AMERICA CORP /DE/ (6), WELLS FARGO & COMPANY/MN (3).